Polestar Communications

Polestar Communications is a specialist medical communications agency that provides strategic scientific engagement and medical affairs services to the global pharmaceutical and biotechnology industries. Founded in 2010 and headquartered in the United Kingdom, the company focuses on high-science therapeutic areas, including oncology and rare diseases. Their core offerings include publication planning, medical education, and strategic consultancy designed to bridge the gap between clinical data and clinical practice. In January 2021, Polestar was acquired by Fishawack Health (now Avalere Health) to enhance the group's scientific and strategic capabilities. The agency is recognized for its expertise in navigating complex regulatory and market access environments for innovative therapies.